Literature DB >> 29545350

Impact of age on genetics and treatment efficacy in follicular lymphoma.

Stefan Alig1, Vindi Jurinovic1,2, Alessandro Pastore3, Deepak Bararia1, Sarah Häbe1, Johannes C Hellmuth1,4, Robert Kridel5, Randy Gascoyne6,7, Christian Schmidt1, Anna-Katharina Zöllner1, Christian Buske8, Martin Dreyling1, Michael Unterhalt1, Wolfgang Hiddemann1,9, Eva Hoster1,2, Oliver Weigert10,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29545350      PMCID： PMC6068024          DOI： 10.3324/haematol.2018.187773

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.

Authors:  Wolfgang Hiddemann; Michael Kneba; Martin Dreyling; Norbert Schmitz; Eva Lengfelder; Rudolf Schmits; Marcel Reiser; Bernd Metzner; Harriet Harder; Susanna Hegewisch-Becker; Thomas Fischer; Martin Kropff; Hans-Edgar Reis; Mathias Freund; Bernhard Wörmann; Roland Fuchs; Manfred Planker; Jörg Schimke; Hartmut Eimermacher; Lorenz Trümper; Ali Aldaoud; Reza Parwaresch; Michael Unterhalt
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

2.  The origin and evolution of mutations in acute myeloid leukemia.

Authors:  John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

3.  Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States.

Authors:  Chadi Nabhan; Michelle Byrtek; Ashish Rai; Keith Dawson; Xiaolei Zhou; Brian K Link; Jonathan W Friedberg; Andrew D Zelenetz; Matthew J Maurer; James R Cerhan; Christopher R Flowers
Journal:  Br J Haematol       Date:  2015-04-07       Impact factor: 6.998

4.  Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Authors:  Alessandro Pastore; Vindi Jurinovic; Robert Kridel; Eva Hoster; Annette M Staiger; Monika Szczepanowski; Christiane Pott; Nadja Kopp; Mark Murakami; Heike Horn; Ellen Leich; Alden A Moccia; Anja Mottok; Ashwini Sunkavalli; Paul Van Hummelen; Matthew Ducar; Daisuke Ennishi; Hennady P Shulha; Christoffer Hother; Joseph M Connors; Laurie H Sehn; Martin Dreyling; Donna Neuberg; Peter Möller; Alfred C Feller; Martin L Hansmann; Harald Stein; Andreas Rosenwald; German Ott; Wolfram Klapper; Michael Unterhalt; Wolfgang Hiddemann; Randy D Gascoyne; David M Weinstock; Oliver Weigert
Journal:  Lancet Oncol       Date:  2015-08-06       Impact factor: 41.316

5.  Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

Authors:  C Casulo; B Day; K L Dawson; X Zhou; C R Flowers; C M Farber; J D Hainsworth; J R Cerhan; B K Link; A D Zelenetz; J W Friedberg
Journal:  Ann Oncol       Date:  2015-09-11       Impact factor: 32.976

6.  Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Stefano Luminari; Armando Lopez-Guillermo; Umberto Vitolo; Barbara Pro; Stefano Pileri; Alessandro Pulsoni; Pierre Soubeyran; Sergio Cortelazzo; Giovanni Martinelli; Maurizio Martelli; Luigi Rigacci; Luca Arcaini; Francesco Di Raimondo; Francesco Merli; Elena Sabattini; Peter McLaughlin; Philippe Solal-Céligny
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

7.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

Review 8.  The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.

Authors:  Oliver Weigert; David M Weinstock
Journal:  Blood       Date:  2012-08-06       Impact factor: 22.113

9.  Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.

Authors:  Ian W Flinn; Richard van der Jagt; Brad S Kahl; Peter Wood; Tim E Hawkins; David Macdonald; Mark Hertzberg; Yiu-Lam Kwan; David Simpson; Michael Craig; Kathryn Kolibaba; Samar Issa; Regina Clementi; Doreen M Hallman; Mihaela Munteanu; Ling Chen; John M Burke
Journal:  Blood       Date:  2014-03-03       Impact factor: 22.113

10.  Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.

Authors:  Robert Marcus; Andrew Davies; Kiyoshi Ando; Wolfram Klapper; Stephen Opat; Carolyn Owen; Elizabeth Phillips; Randeep Sangha; Rudolf Schlag; John F Seymour; William Townsend; Marek Trněný; Michael Wenger; Günter Fingerle-Rowson; Kaspar Rufibach; Tom Moore; Michael Herold; Wolfgang Hiddemann
Journal:  N Engl J Med       Date:  2017-10-05       Impact factor: 91.245
View more
  4 in total

1.  Impact of age on clinical risk scores in follicular lymphoma.

Authors:  Stefan Alig; Vindi Jurinovic; Alessandro Pastore; Sarah Haebe; Christian Schmidt; Anna-Katharina Zoellner; Martin Dreyling; Michael Unterhalt; Eva Hoster; Wolfgang Hiddemann; Oliver Weigert
Journal:  Blood Adv       Date:  2019-04-09

2.  Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.

Authors:  Stefan Alig; Vindi Jurinovic; Mohammad Shahrokh Esfahani; Sarah Haebe; Verena Passerini; Johannes C Hellmuth; Erik Gaitzsch; William Keay; Natyra Tahiri; Anna Zoellner; Andreas Rosenwald; Wolfram Klapper; Harald Stein; Alfred Feller; German Ott; Annette M Staiger; Heike Horn; Martin L Hansmann; Christiane Pott; Michael Unterhalt; Christian Schmidt; Martin Dreyling; Ash A Alizadeh; Wolfgang Hiddemann; Eva Hoster; Oliver Weigert
Journal:  Blood Adv       Date:  2020-09-22

3.  Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts.

Authors:  Clémentine Sarkozy; Matthew J Maurer; Brian K Link; Hervé Ghesquieres; Emmanuelle Nicolas; Carrie A Thompson; Alexandra Traverse-Glehen; Andrew L Feldman; Cristine Allmer; Susan L Slager; Stephen M Ansell; Thomas M Habermann; Emmanuel Bachy; James R Cerhan; Gilles Salles
Journal:  J Clin Oncol       Date:  2018-11-27       Impact factor: 44.544

4.  Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials.

Authors:  Carla Casulo; Jesse G Dixon; Fang-Shu Ou; Eva Hoster; Bruce A Peterson; Howard S Hochster; Pauline Brice; Marco Ladetto; Wolfgang Hiddemann; Robert Marcus; Eva Kimby; Michael Herold; Tina Nielsen; Franck Morschhauser; Mathias Rummel; Anton Hagenbeek; Umberto Vitolo; Gilles A Salles; Qian Shi; Christopher R Flowers
Journal:  Blood Adv       Date:  2021-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.